Cannabinoids were more potent in older mice, and low doses had opposite effects in young versus old animals

The synthetic cannabinoid CP55940 was more potent and effective in aged mice than young adults, with stronger pain relief and movement suppression. Low doses paradoxically stimulated movement in young mice but not in old mice.

Hodges, Erik L et al.·NPJ aging and mechanisms of disease·2020·Preliminary EvidenceAnimal StudyAnimal Study
RTHC-02613Animal StudyPreliminary Evidence2020RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
Preliminary Evidence
Sample
Not reported

What This Study Found

CP55940 produced greater antinociception (pain relief) and locomotor inhibition in aged (21-24 month) compared to young-adult (4 month) mice. Low doses paradoxically stimulated movement in young mice (hormesis), but this effect was diminished in aged animals. Both CB1 and CB2 receptors mediated the effects.

Key Numbers

Young-adult mice: 4 months old. Aged mice: 21-24 months old. Aged mice showed exaggerated antinociception and locomotor inhibition compared to young adults.

How They Did This

Young-adult and aged C57BL/6 mice received CP55940 at multiple doses. Locomotion, body temperature, thermal pain response (nociception), and fecal output were measured.

Why This Research Matters

Cannabis use among older adults is increasing rapidly, yet almost no preclinical data exist in aged models. The greater potency in older animals suggests that elderly users may need lower doses and face different risk profiles.

The Bigger Picture

The age-dependent difference in cannabinoid response has direct clinical relevance as more seniors use cannabis for pain and other conditions. Standard dosing recommendations developed in younger populations may be inappropriate for elderly users.

What This Study Doesn't Tell Us

Animal study using a synthetic cannabinoid (not THC or CBD). Mouse aging does not perfectly model human aging. Only male and female mice of two age groups were compared.

Questions This Raises

  • ?Do human seniors also show heightened sensitivity to cannabinoids?
  • ?Should cannabis dosing guidelines be age-adjusted?
  • ?What changes in the endocannabinoid system explain the age difference?

Trust & Context

Key Stat:
Cannabinoids more potent in aged vs. young-adult mice
Evidence Grade:
Preliminary: animal study comparing two age groups with a synthetic cannabinoid.
Study Age:
Published in 2020 in npj Aging and Mechanisms of Disease.
Original Title:
Age-dependent hormesis-like effects of the synthetic cannabinoid CP55940 in C57BL/6 mice.
Published In:
NPJ aging and mechanisms of disease, 6, 7 (2020)
Database ID:
RTHC-02613

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Why are cannabinoids more potent in older animals?

The study found the effect but did not fully explain the mechanism. Possible reasons include age-related changes in cannabinoid receptor density, altered endocannabinoid levels, or changes in drug metabolism in older animals.

What is the hormesis effect?

At low doses, CP55940 paradoxically stimulated movement in young mice rather than suppressing it. This bidirectional dose effect was largely absent in aged mice, suggesting the endocannabinoid system responds differently to low-dose stimulation as it ages.

Read More on RethinkTHC

Cite This Study

RTHC-02613·https://rethinkthc.com/research/RTHC-02613

APA

Hodges, Erik L; Marshall, Jessica P; Ashpole, Nicole M. (2020). Age-dependent hormesis-like effects of the synthetic cannabinoid CP55940 in C57BL/6 mice.. NPJ aging and mechanisms of disease, 6, 7. https://doi.org/10.1038/s41514-020-0045-7

MLA

Hodges, Erik L, et al. "Age-dependent hormesis-like effects of the synthetic cannabinoid CP55940 in C57BL/6 mice.." NPJ aging and mechanisms of disease, 2020. https://doi.org/10.1038/s41514-020-0045-7

RethinkTHC

RethinkTHC Research Database. "Age-dependent hormesis-like effects of the synthetic cannabi..." RTHC-02613. Retrieved from https://rethinkthc.com/research/hodges-2020-agedependent-hormesislike-effects-of

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.